| UniProt ID | CR025_HUMAN | |
|---|---|---|
| UniProt AC | Q96B23 | |
| Protein Name | Uncharacterized protein C18orf25 | |
| Gene Name | C18orf25 {ECO:0000312|HGNC:HGNC:28172} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 404 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MKMEEAVGKVEELIESEAPPKASEQETAKEEDGSVELESQVQKDGVADSTVISSMPCLLMELRRDSSESQLASTESDKPTTGRVYESDSSNHCMLSPSSSGHLADSDTLSSAEENEPSQAETAVEGDPSGVSGATVGRKSRRSRSESETSTMAAKKNRQSSDKQNGRVAKVKGHRSQKHKERIRLLRQKREAAARKKYNLLQDSSTSDSDLTCDSSTSSSDDDEEVSGSSKTITAEIPDGPPVVAHYDMSDTNSDPEVVNVDNLLAAAVVQEHSNSVGGQDTGATWRTSGLLEELNAEAGHLDPGFLASDKTSAGNAPLNEEINIASSDSEVEIVGVQEHARCVHPRGGVIQSVSSWKHGSGTQYVSTRQTQSWTAVTPQQTWASPAEVVDLTLDEDSRRKYLL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Sumoylation | ------MKMEEAVGK ------CCHHHHHHH | 55.83 | - | |
| 2 | Sumoylation | ------MKMEEAVGK ------CCHHHHHHH | 55.83 | - | |
| 16 | Phosphorylation | KVEELIESEAPPKAS HHHHHHHCCCCCCCC | 31.87 | 25159151 | |
| 21 | Acetylation | IESEAPPKASEQETA HHCCCCCCCCHHHHH | 64.58 | 11922795 | |
| 21 | Ubiquitination | IESEAPPKASEQETA HHCCCCCCCCHHHHH | 64.58 | 33845483 | |
| 23 | Phosphorylation | SEAPPKASEQETAKE CCCCCCCCHHHHHCC | 46.03 | 29978859 | |
| 27 | Phosphorylation | PKASEQETAKEEDGS CCCCHHHHHCCCCCC | 42.60 | 29978859 | |
| 29 | Sumoylation | ASEQETAKEEDGSVE CCHHHHHCCCCCCEE | 69.89 | - | |
| 29 | Sumoylation | ASEQETAKEEDGSVE CCHHHHHCCCCCCEE | 69.89 | - | |
| 34 | Phosphorylation | TAKEEDGSVELESQV HHCCCCCCEEEEHHH | 25.41 | 29255136 | |
| 39 | Phosphorylation | DGSVELESQVQKDGV CCCEEEEHHHCCCCC | 48.56 | 17525332 | |
| 49 | Phosphorylation | QKDGVADSTVISSMP CCCCCCCHHHHHHHH | 18.16 | 30377224 | |
| 50 | Phosphorylation | KDGVADSTVISSMPC CCCCCCHHHHHHHHH | 23.54 | 30377224 | |
| 53 | Phosphorylation | VADSTVISSMPCLLM CCCHHHHHHHHHHHH | 19.09 | 30377224 | |
| 54 | Phosphorylation | ADSTVISSMPCLLME CCHHHHHHHHHHHHH | 18.67 | 28348404 | |
| 57 | Glutathionylation | TVISSMPCLLMELRR HHHHHHHHHHHHHHC | 3.22 | 22555962 | |
| 66 | Phosphorylation | LMELRRDSSESQLAS HHHHHCCCCHHHHCC | 33.91 | 29255136 | |
| 67 | Phosphorylation | MELRRDSSESQLAST HHHHCCCCHHHHCCC | 45.62 | 29255136 | |
| 69 | Phosphorylation | LRRDSSESQLASTES HHCCCCHHHHCCCCC | 32.23 | 29255136 | |
| 73 | Phosphorylation | SSESQLASTESDKPT CCHHHHCCCCCCCCC | 41.10 | 29255136 | |
| 74 | Phosphorylation | SESQLASTESDKPTT CHHHHCCCCCCCCCC | 33.62 | 29255136 | |
| 76 | Phosphorylation | SQLASTESDKPTTGR HHHCCCCCCCCCCCC | 51.53 | 29255136 | |
| 78 | Ubiquitination | LASTESDKPTTGRVY HCCCCCCCCCCCCCE | 54.25 | 24816145 | |
| 80 | Phosphorylation | STESDKPTTGRVYES CCCCCCCCCCCCEEC | 47.85 | 29255136 | |
| 81 | Phosphorylation | TESDKPTTGRVYESD CCCCCCCCCCCEECC | 31.36 | 29255136 | |
| 132 | Phosphorylation | EGDPSGVSGATVGRK CCCCCCCCCCCCCCC | 26.66 | - | |
| 135 | Phosphorylation | PSGVSGATVGRKSRR CCCCCCCCCCCCCCC | 27.33 | - | |
| 140 | Phosphorylation | GATVGRKSRRSRSES CCCCCCCCCCCCCHH | 31.40 | 26074081 | |
| 143 | Phosphorylation | VGRKSRRSRSESETS CCCCCCCCCCHHHHH | 38.76 | 29255136 | |
| 145 | Phosphorylation | RKSRRSRSESETSTM CCCCCCCCHHHHHHH | 46.88 | 29255136 | |
| 147 | Phosphorylation | SRRSRSESETSTMAA CCCCCCHHHHHHHHH | 47.63 | 29255136 | |
| 149 | Phosphorylation | RSRSESETSTMAAKK CCCCHHHHHHHHHHH | 38.48 | 29255136 | |
| 150 | Phosphorylation | SRSESETSTMAAKKN CCCHHHHHHHHHHHH | 16.48 | 29255136 | |
| 151 | Phosphorylation | RSESETSTMAAKKNR CCHHHHHHHHHHHHC | 20.46 | 29255136 | |
| 155 | Ubiquitination | ETSTMAAKKNRQSSD HHHHHHHHHHCCCCC | 40.83 | 24816145 | |
| 155 | Acetylation | ETSTMAAKKNRQSSD HHHHHHHHHHCCCCC | 40.83 | 25953088 | |
| 232 (in isoform 2) | Phosphorylation | - | 26.05 | 25159151 | |
| 248 (in isoform 2) | Phosphorylation | - | 21.90 | 28348404 | |
| 248 | Phosphorylation | PPVVAHYDMSDTNSD CCEEEEEECCCCCCC | 21.90 | 27251275 | |
| 297 | Ubiquitination | GLLEELNAEAGHLDP HHHHHHHHHCCCCCC | 22.20 | 32015554 | |
| 309 | Phosphorylation | LDPGFLASDKTSAGN CCCCCCCCCCCCCCC | 41.61 | - | |
| 312 | Phosphorylation | GFLASDKTSAGNAPL CCCCCCCCCCCCCCC | 47.02 | 24144214 | |
| 313 | Phosphorylation | FLASDKTSAGNAPLN CCCCCCCCCCCCCCC | 35.47 | 24144214 | |
| 326 | Phosphorylation | LNEEINIASSDSEVE CCCCCEECCCCCCEE | 30.77 | 26657352 | |
| 327 | Phosphorylation | NEEINIASSDSEVEI CCCCEECCCCCCEEE | 35.81 | 18691976 | |
| 327 | Phosphorylation | NEEINIASSDSEVEI CCCCEECCCCCCEEE | 35.81 | 17192257 | |
| 328 | Phosphorylation | EEINIASSDSEVEIV CCCEECCCCCCEEEE | 46.45 | 21406692 | |
| 328 | Phosphorylation | EEINIASSDSEVEIV CCCEECCCCCCEEEE | 46.45 | 29743597 | |
| 329 | Phosphorylation | EINIASSDSEVEIVG CCEECCCCCCEEEEE | 45.55 | 29743597 | |
| 330 | Phosphorylation | INIASSDSEVEIVGV CEECCCCCCEEEEEE | 49.51 | 17192257 | |
| 330 | Phosphorylation | INIASSDSEVEIVGV CEECCCCCCEEEEEE | 49.51 | 17081983 | |
| 346 | Methylation | EHARCVHPRGGVIQS CCCEEECCCCCEEEE | 39.35 | 24129315 | |
| 347 | Methylation | HARCVHPRGGVIQSV CCEEECCCCCEEEEE | 38.89 | 24129315 | |
| 352 | Phosphorylation | HPRGGVIQSVSSWKH CCCCCEEEEECCEEC | 16.91 | 20068231 | |
| 354 | Phosphorylation | RGGVIQSVSSWKHGS CCCEEEEECCEECCC | 35.41 | 20068231 | |
| 355 | O-linked_Glycosylation | GGVIQSVSSWKHGSG CCEEEEECCEECCCC | 37.68 | 23301498 | |
| 355 | Phosphorylation | GGVIQSVSSWKHGSG CCEEEEECCEECCCC | 37.68 | 23401153 | |
| 356 | Phosphorylation | GVIQSVSSWKHGSGT CEEEEECCEECCCCC | 6.80 | 24719451 | |
| 357 | Ubiquitination | VIQSVSSWKHGSGTQ EEEEECCEECCCCCE | 39.78 | - | |
| 357 | Sumoylation | VIQSVSSWKHGSGTQ EEEEECCEECCCCCE | 39.78 | - | |
| 357 | Sumoylation | VIQSVSSWKHGSGTQ EEEEECCEECCCCCE | 39.78 | - | |
| 358 | Ubiquitination | IQSVSSWKHGSGTQY EEEECCEECCCCCEE | 29.41 | 32015554 | |
| 358 | Sumoylation | IQSVSSWKHGSGTQY EEEECCEECCCCCEE | 29.41 | 28112733 | |
| 360 | Phosphorylation | SVSSWKHGSGTQYVS EECCEECCCCCEEEE | 38.08 | 23401153 | |
| 362 | Phosphorylation | SSWKHGSGTQYVSTR CCEECCCCCEEEECE | 20.58 | 28796482 | |
| 363 | Phosphorylation | SWKHGSGTQYVSTRQ CEECCCCCEEEECEE | 39.91 | 27251275 | |
| 364 | Phosphorylation | WKHGSGTQYVSTRQT EECCCCCEEEECEEC | 9.01 | 28796482 | |
| 366 | Phosphorylation | HGSGTQYVSTRQTQS CCCCCEEEECEECCC | 16.97 | 28796482 | |
| 367 | Phosphorylation | GSGTQYVSTRQTQSW CCCCEEEECEECCCE | 19.42 | 28796482 | |
| 381 | Phosphorylation | WTAVTPQQTWASPAE EEEECCCCCCCCCCC | 20.11 | 28348404 | |
| 384 | Phosphorylation | VTPQQTWASPAEVVD ECCCCCCCCCCCEEE | 19.06 | 23917254 | |
| 392 | Phosphorylation | SPAEVVDLTLDEDSR CCCCEEEEECCCCHH | 27.92 | 23917254 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CR025_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CR025_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CR025_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| BOP1_HUMAN | BOP1 | physical | 22863883 | |
| GPN1_HUMAN | GPN1 | physical | 22863883 | |
| SC24A_HUMAN | SEC24A | physical | 22863883 | |
| GLYC_HUMAN | SHMT1 | physical | 22863883 | |
| ZRAB2_HUMAN | ZRANB2 | physical | 22863883 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66; SER-76 AND SER-145,AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; SER-327 ANDSER-329, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66; SER-326; SER-327 ANDSER-329, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39; SER-66 AND SER-69,AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66; SER-326; SER-327 ANDSER-329, AND MASS SPECTROMETRY. | |